This regulatory divide creates a dual-track market for GLP-1 therapies that compels the careful calibration of branding, pricing and access strategies
Both Wegovy and Contrave are FDA-approved for weight management, but eligibility depends on specific health factors
In this blog post, we will explore retatrutides mechanism of action, its benefits for blood sugar control, and its potential as a valuable tool in managing diabetes
Taken altogether, these mechanisms explain the clinical use of GLP-1RAs as beneficial treatment options for T2DM and obesity
At the same time, compounded drugs are not FDA-approved, meaning the agency has not evaluated them for safety, effectiveness, or quality prior to marketing
GLP-1 receptor agonists may lead to weight loss